4-羟基-7-甲氧基喹啉-2-酮 | 27037-34-9

• 物质功能分类: 医药中间体 - 杂环化合物 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4-羟基-7-甲氧基喹啉-2-酮
• 中文别名: 2,4-二羟基-7-甲氧基喹啉
• 英文名称: 4-hydroxy-7-methoxyquinolin-2(1H)-one
• 英文别名: 4-hydroxy-7-methoxyquinoline-2(1H)-one；4-hydroxy-7-methoxycarbostyril；4-Hydroxy-7-methoxy-1H-quinolin-2-one
• CAS: 27037-34-9
• 化学式: C₁₀H₉NO₃
• mdl: MFCD00101261
• 分子量: 191.186
• InChiKey: RUWKOLGTLOFEMK-UHFFFAOYSA-N

物化性质

• 熔点：
  339-340 °C
• 沸点：
  429.5±45.0 °C(Predicted)
• 密度：
  1.355±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xn
• 危险类别码：
  R22
• 海关编码：
  2933499090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 4-Hydroxy-7-Methoxy-1H-Quinolin-2-One
: CVT00065
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

---

SECTION 3: Composition/information on ingredients
Substances
Molecular weight : 191,18 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
4-Hydroxy-7-Methoxy-1H-Quinolin-2-One
Acute Tox. 4; H302 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
4-Hydroxy-7-Methoxy-1H-Quinolin-2-One
Xn, R22 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting point/freezing No data available
point
f) Initial boiling point and No data available
boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure No data available
l) Vapour density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: n- No data available
octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
Other safety information
No data available

---

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
No data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-羟基-7-甲氧基喹啉-2-酮 在 磺酰氯 、 硫酸 作用下， 以 1,4-二氧六环 、 水 、 溶剂黄146 为溶剂， 反应 2.0h， 生成 6-chloro-3-hydroxy-3-(4-hydroxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinoline
  参考文献：
  名称：

  非甾体抗炎药。3 †。3-羟基-3-羟基苯基-2,4-二氧-1,2,3,4-四氢喹啉的合成

  摘要：

  奎尼沙汀5a-c或其缩醛4a-c与苯酚6a-i的酸催化缩合产生许多3-羟基-3-羟基苯基-2,4-二氧代-1,2,3,4-四氢喹啉7a -s被认为是潜在的抗炎药。

  DOI：

  10.1002/jhet.5570220431
• 作为产物：
  描述：

  Malonsaeure-bis-<3-methoxy-anilid> 在 PPA 作用下， 反应 6.0h， 以75%的产率得到4-羟基-7-甲氧基喹啉-2-酮
  参考文献：
  名称：

  芸香科异戊二烯基，呋喃基和吡喃基喹啉生物碱的简便合成方法

  摘要：

  描述了一种方便的合成4-羟基-3-异戊烯基-2-喹诺酮的方法，该方法被认为是芸香科异戊二烯基，呋喃基和吡喃喹啉生物碱的前体。该方法涉及2，4-二羟基喹啉的C，C-二烯丙基化，然后使用碲化氢钠试剂进行部分脱甲酰化。

  DOI：

  10.1016/0040-4020(89)80106-1

文献信息

• Hepatitis C virus inhibitors
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US09527885B2

  公开（公告）日：2016-12-27

  Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

  揭示了具有一般式（I）的丙型肝炎病毒抑制剂。还公开了包含这些化合物的组合物以及使用这些化合物抑制HCV的方法。
• Hepatitis C Virus Inhibitors
  申请人：Hiebert Sheldon

  公开号：US20130115190A1

  公开（公告）日：2013-05-09

  Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

  丙型肝炎病毒抑制剂具有通式（I）如下。还公开了包含这些化合物的组合物以及使用这些化合物抑制HCV的方法。
• Discovery and Biological Activity of 6BrCaQ as an Inhibitor of the Hsp90 Protein Folding Machinery
  作者：Davide Audisio、Samir Messaoudi、Lukasz Cegielkowski、Jean-François Peyrat、Jean-Daniel Brion、Délphine Methy-Gonnot、Christine Radanyi、Jack-Michel Renoir、Mouâd Alami

  DOI：10.1002/cmdc.201000489

  日期：2011.5.2

  the simplified 3‐aminoquinolein‐2‐one analogue 2 b (6BrCaQ), which manifests micromolar activity against a panel of cancer cell lines. The molecular signature of Hsp90 inhibition was assessed by depletion of standard known Hsp90 client proteins. Finally, processing and activation of caspases 7, 8, and 9, and the subsequent cleavage of PARP by 6BrCaQ, suggest stimulation of apoptosis through both extrinsic

  热休克蛋白90（Hsp90）由于其在与细胞增殖和生存能力相关的多种信号通路的十字路口的作用而成为合理癌症治疗发展中的重要目标。在这里，合成了一系列新型的Hsp90抑制剂，其中含有一个quinolein-2-one支架，并在细胞增殖试验中进行了评估。这些结构-活性关系研究的结果使鉴定简化的3-氨基喹诺酮-2-酮类似物2 b成为可能。（6BrCaQ），对一组癌细胞系表现出微摩尔活性。Hsp90抑制的分子特征是通过消耗已知的标准Hsp90客户蛋白质来评估的。最后，胱天蛋白酶7、8和9的加工和激活以及随后的6BrCaQ对PARP的切割，提示通过外在和内在途径刺激凋亡。
• Synthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1<i>H</i>)-one derivatives for anticancer activity
  作者：Yi-Fong Chen、Yi-Chien Lin、Susan L Morris-Natschke、Chen-Fang Wei、Ting-Chen Shen、Hui-Yi Lin、Mei-Hua Hsu、Li-Chen Chou、Yu Zhao、Sheng-Chu Kuo、Kuo-Hsiung Lee、Li-Jiau Huang

  DOI：10.1111/bph.12992

  日期：2015.3

  BACKGROUND AND PURPOSE 4-Phenylquinolin-2(1H)-one (4-PQ) derivatives can induce cancer cell apoptosis. Additional new 4-PQ analogs were investigated as more effective, less toxic antitumour agents. EXPERIMENTAL APPROACH Forty-five 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives were synthesized. Antiproliferative activities were evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2

  背景和目的 4-Phenylquinolin-2(1H)-one (4-PQ) 衍生物可诱导癌细胞凋亡。其他新的 4-PQ 类似物被研究为更有效、毒性更小的抗肿瘤剂。实验方法合成了 45 个 6,7,8-取代的 4-取代苄氧基喹啉-2(1H)-one 衍生物。使用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物测定评估抗增殖活性，并建立结构-活性关系相关性。化合物 9b、9c、9e 和 11e 也针对 National Cancer Institute-60 人类癌细胞系面板进行了评估。Hoechst 33258 和 Annexin V-FITC/PI 染色检测用于检测细胞凋亡，同时通过荧光显微镜检测微管聚合的抑制。通过流式细胞术和凋亡相关蛋白（活性 caspase-3、-8 和 -9、procaspase-3、-8、-9、PARP、Bid、Bcl-xL 和 Bcl-2）评估
• Syntheses and Fluorescent Properties of 6-Methoxy-2-oxoquinoline-3,4-dicarbonitriles and 6,7-Dimethoxy-2-oxoquinoline-3,4-dicarbonitriles
  作者：Guy Crépin Enoua、Günther Lahm、Georg Uray、Wolfgang Stadlbauer

  DOI：10.1002/jhet.1865

  日期：2014.8

  4-Chlorocarbostyrils , , , , with methoxy substituents in 6, 7, or 6,7-position react with potassium cyanide in a p-toluenesulfinate mediated reaction either to the highly fluorescent and stable 2-oxoquinoline-3,4-dicarbonitriles , , , or at slightly lower temperatures to 4-monocarbonitriles , , . 4-Chlorocarbostyril and lithium p-toluenesulfinate gave pure 4-toluenesulfonylquinolone , which reacted

  4-氯咔啉 ， ， ， ， 在6、7或6,7位的甲氧基取代基与 对甲苯磺酸酯介导的对高荧光和稳定的2-氧代喹啉-3,4-二腈的反应中的氰化钾， ， ， 或在较低的温度下生成4-单腈 ， ， 。4-氯卡巴斯蒂利 和 对甲苯磺酸锂得到纯的4-甲苯磺酰基喹诺酮与氰化钾反应生成单腈 或二腈 ，取决于反应条件。4-三氟甲基喹诺酮类 和 由合适的甲氧基苯胺和4,4,4-三氟乙酰乙酸制备用于荧光比较的样品。